Company intelligence / Profile preview

Gam-Farma

Sant Cugat del Vallès, Barcelona, Spain

Ownership: Private
Development stage: Other

Overview

Gam-Farma is primarily a commercial-stage pharmaceutical company. Historically, it has supported clinical trials for its parent company Almirall's original molecules, such as ebastine (Ebastel) for allergic rhinitis and aceclofenac (Airtal) for inflammatory pain. Current activities are focused on the marketing and distribution of specialty medicines rather than independent early-stage R&D.

Therapeutic areas: ImmunologyNeurologyDermatologyRheumatologyMen's Health
Modalities: Small molecule
Industry: Biotech

Partnerships

AlmirallAstraZeneca

Beyond the preview

Go deeper on Gam-Farma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gam-Farma.

Explore the full profile